General MedicationsORALGeneric

PHENDIMETRAZINE TARTRATE

Standard Dose

35MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: UNKNOWN Marketing status: Discontinued

Summary

Approval overview PHENDIMETRAZINE TARTRATE is listed in Drugs@FDA under application 203600 (ANDA).

Review priority: UNKNOWN Marketing status: Discontinued Active ingredient PHENDIMETRAZINE TARTRATE Form and strength TABLET;ORAL - 35MG Sponsor MPP PHARMA Submission history Latest submission status date: 2024-08-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview PHENDIMETRAZINE TARTRATE is listed in Drugs@FDA under application 203600 (ANDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient PHENDIMETRAZINE TARTRATE Form and strength TABLET;ORAL - 35MG Sponsor MPP PHARMA Submission history Latest submission status date: 2024-08-02 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: UNKNOWN

Interaction Notes

No interaction notes stored yet.